-transparent.png){kind=logo}
Three newborn infants who developed hyperbilirubinemia due to blood group incompatibility were treated with high-dose gammaglobulin. Hyperbilirubinemia was caused by Rhesus (Rh) incompatibility (anti-E + anti-c) in Infant 1 and ABO incompatibility (anti-B) in Infants 2 and 3. Hyperbilirubinemia was refractory to conventional phototherapy but responded well to intravenous gammaglobulin (IVGG) at a dose of 1 g/kg in all infants. No adverse effects were observed. These findings suggest that high-dose IVGG may be useful in the treatment of hyperbilirubinemia due to isoimmune haemolytic disease resistant to phototherapy.
Related Publications
K Sato, and
T Hara, and
T Kondo, and
H Iwao, and
S Honda, and
K Ueda
March 2000,
Acta paediatrica (Oslo, Norway : 1992),
K Sato, and
T Hara, and
T Kondo, and
H Iwao, and
S Honda, and
K Ueda
February 1999,
Acta paediatrica (Oslo, Norway : 1992),
K Sato, and
T Hara, and
T Kondo, and
H Iwao, and
S Honda, and
K Ueda
May 1988,
The Journal of pediatrics,
K Sato, and
T Hara, and
T Kondo, and
H Iwao, and
S Honda, and
K Ueda
September 2009,
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
K Sato, and
T Hara, and
T Kondo, and
H Iwao, and
S Honda, and
K Ueda
November 1987,
American journal of hematology,
K Sato, and
T Hara, and
T Kondo, and
H Iwao, and
S Honda, and
K Ueda
April 1991,
Lancet (London, England),
K Sato, and
T Hara, and
T Kondo, and
H Iwao, and
S Honda, and
K Ueda
January 1989,
Metabolic, pediatric, and systemic ophthalmology (New York, N.Y. : 1985),
K Sato, and
T Hara, and
T Kondo, and
H Iwao, and
S Honda, and
K Ueda
October 1983,
The Journal of pediatrics,
K Sato, and
T Hara, and
T Kondo, and
H Iwao, and
S Honda, and
K Ueda
January 1991,
Acta paediatrica Scandinavica,
K Sato, and
T Hara, and
T Kondo, and
H Iwao, and
S Honda, and
K Ueda
January 1995,
Vox sanguinis,
